Clinical Trials Browser

Phase 3 × INDUSTRY × Gastro-Intestinal Stromal Tumour × Clear all

NCT02009423 2018-12-14

Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence

Phase 3 Terminated

Gastro-Intestinal Stromal Tumour